Direct targeted therapy for MLL-fusion-driven high-risk acute leukaemias.

S Cantilena, L Gasparoli, D Pal, O Heidenreich, JH Klusmann, JHA Martens, A Faille, AJ Warren, M Karsa, R Pandher, K Somers, O Williams, Boer J de

Research output: Contribution to journalArticle (Academic Journal)peer-review

Original languageUndefined/Unknown
JournalClinical and translational medicine
Publication statusPublished - Jun 2022

Cite this